FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

61 letters match. Newest first.

  1. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  2. Rohto Pharmaceutical Co., Ltd.

    FDA cites Rohto Vietnam eye-drop plant for falsified sterility records, poor aseptic practices, and unapproved Cooling Eye Drops.

    High risk
  3. PReye, LLC

    FDA warned PReye, LLC that its unapproved eye drop PReye Vitamin SEE was made without sterile controls in an unclassified office.

    High risk
  4. BlephEx, LLC

    FDA says BlephEx sold three eye devices without required FDA clearance and missed device reports.

    High risk
  5. RC Outsourcing, LLC

    FDA warned outsourcing facility RC Outsourcing of Lowellville, Ohio, that its sterile drugs were made under insanitary conditions that risk contamination.

    High risk
  6. Boothwyn Pharmacy, LLC

    Boothwyn Pharmacy made sterile drugs in insanitary conditions and shipped lots that failed sterility and potency tests.

    High risk
  7. PQ Pharmacy, LLC

    FDA warns PQ Pharmacy, a Florida sterile drug compounder, that its products were made under unsafe conditions.

    High risk
  8. VarunKart Group LLC dba Organic Wellnesses

    VarunKart Group sells unapproved Ayurvedic and homeopathic drugs with serious disease claims.

    High risk
  9. Distacart Inc.

    FDA says Distacart's website sells unapproved drugs, some claimed for malaria, asthma, depression and eye conditions.

    High risk
  10. Swift Digital Group LLC dba Swadesii

    FDA warned Swadesii that its website sells unapproved drugs with claims to treat serious conditions including measles, cancer and Alzheimer's.

    High risk
  11. Mahita LLC dba PushMyCart

    FDA told online seller PushMyCart its website and Facebook posts sell unapproved drugs claiming to treat measles, cancer, diabetes and Parkinson's.

    High risk
  12. Apotex Inc.

    FDA cited Apotex's Richmond Hill sterile plant for failed investigations and aseptic contamination risks, prompting recalls.

    High risk
  13. Melcare Biomedical Pty Ltd

    Australia's Melcare Biomedical sells Optimel Manuka+ eye gel and drops in the US as unapproved drugs with honey as an active ingredient.

    High risk
  14. Green Vitality dba Gr33n

    FDA warned Green Vitality dba Gr33n that its Jimerito Honey Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  15. My Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD

    FDA warned My Holistic Honey that its honey eye drops are an unapproved new drug sold with drug claims.

    High risk
  16. Homeopathic Educational Services dba Homeopathic Family Medicine

    FDA says Homeopathic Family Medicine sells unapproved Cineraria Maritima Eye Drops for cataracts online.

    High risk
  17. Mel Honey US

    FDA warned Mel Honey US that its Jimerito (Melipona) Honey eye drops are an unapproved new drug.

    High risk
  18. Supply Center USA

    Supply Center USA offered unapproved Similasan and Boiron eye drug products for sale online.

    High risk
  19. Trew Balance

    FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  20. Life Enthusiast Co-op

    FDA tells Life Enthusiast Co-op its three eye products sold online are unapproved new drugs.

    High risk
  21. Oasis Medical, Inc.

    FDA cites Oasis Medical for current good manufacturing practice violations in sterile ophthalmic drugs, including particulate contamination and unresolved sterility failures.

    High risk
  22. Covalent Medical

    FDA warned Covalent Medical that its FOCUS PI post-injection eye drops are an unapproved new drug with claims not allowed for over-the-counter eye products.

    Medium
  23. Scope Health Inc

    FDA says Scope Health sold unapproved OTC eye drugs online and misbranded several products.

    High risk
  24. Revitalize Energy, Inc.

    FDA warned Revitalize Energy that its Revitalize Energizing Eye Drops are an unapproved new drug and misbranded.

    High risk
  25. Thea Pharma, Inc.

    FDA warns Thea Pharma that IVIZIA OTC lubricant eye drops are an unapproved and misbranded new drug.

    High risk
  26. EyeTech One, LLC

    FDA warns EyeTech One that its EYELIVIO lubricant eye ointment is an unapproved new drug and misbranded.

    Medium
  27. AACE Pharmaceuticals, Inc.

    AACE Pharmaceuticals distributed adulterated Lubricant PM Ointment made by CMO Brassica with CGMP violations and failed supplier qualification.

    High risk
  28. Microspecialties, LLC

    FDA warned Microspecialties, a Connecticut contract device maker, after it shipped unsterilized eye-surgery injection kits labeled sterile.

    High risk
  29. OSRX, Inc.

    OSRX, a Montana compounding facility, made sterile ophthalmic drugs under insanitary conditions with quality and labeling failures.

    High risk
  30. Aspen Pharmacare Holdings Limited

    FDA warns Aspen subsidiary over sterile OTC drug manufacturing failures including impurity testing, aseptic practices, data integrity, and environmental monitoring.

    High risk
  31. C & A Naturistics

    C & A Naturistics sold unapproved new drugs online, including AK Forte with hidden acetaminophen and diclofenac.

    High risk
  32. Fancy Drops Beauty LLC

    FDA says Fancy Drops Beauty sells unapproved eye drops claimed to change eye color.

    High risk
  33. Omni Lens Pvt. Ltd.

    FDA warns Omni Lens about CGMP failures and misbranding of ophthalmic OTC drugs made by unregistered contract manufacturers.

    High risk
  34. Stokes Healthcare Inc. dba Epicur Pharma

    Sterile compounding facility Epicur Pharma made drugs under insanitary conditions and with serious quality failures, FDA says.

    High risk
  35. Optikem International, Inc.

    FDA cited Optikem International of Denver for unvalidated sterilization and unapproved formulation changes to its Sereine contact lens solutions.

    High risk
  36. Regenerative Processing Plant, LLC

    FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.

    High risk
  37. Velocity Pharma LLC

    Velocity Pharma distributed eye drop drugs made by contract manufacturers with serious manufacturing and sanitation violations.

    High risk
  38. Brassica Pharma Pvt. Ltd.

    FDA warns Brassica Pharma over fabricated sterility and environmental data and poor aseptic controls for sterile drugs.

    High risk
  39. Optikem International Inc.

    FDA warns Optikem International after inspection found inadequate aseptic controls for sterile ophthalmic drugs, including contamination and validation failures.

    High risk
  40. EzriCare LLC

    EzriCare distributed non-sterile Artificial Tears made by a CMO with CGMP violations, linked to a Pseudomonas outbreak.

    High risk
  41. Delsam Pharma LLC

    Delsam Pharma distributed non-sterile, contaminated artificial tears and eye ointment made by its contract manufacturer, FDA found.

    High risk
  42. Neitz Instruments Company Ltd.

    FDA warns Neitz Instruments its ophthalmoscope is misbranded because medical device reporting procedures are inadequate.

    Medium
  43. Belmont Eyecare LLC

    FDA warned Belmont Eyecare that its website sells unapproved new drug eye drops with treatment claims.

    High risk
  44. Dr. Berne’s Whole Health Products

    Dr. Berne’s MSM eye drops and mist are unapproved new drugs; a tested lot had microbial contamination.

    High risk
  45. Amazon.com, Inc.

    FDA warned Amazon for selling seven unapproved eye drug products on Amazon.com.

    High risk
  46. Global Pharma Healthcare Private Limited

    FDA warned Global Pharma Healthcare that non-sterile artificial tears and eye ointment from its India plant were tied to a Pseudomonas outbreak with four deaths.

    High risk
  47. Southern Tier Home Infusion, Inc. dba Pharmacy Innovations

    FDA warned compounding pharmacy Pharmacy Innovations that its sterile drugs were made under insanitary conditions and without valid patient prescriptions.

    High risk
  48. Boiron, Inc.

    FDA warns Boiron that Optique 1 Eye Drops are an unapproved new drug sold with drug claims.

    High risk
  49. Natural Ophthalmics, Inc.

    FDA warned Natural Ophthalmics that six eye drop products are unapproved new drugs sold without FDA approval.

    High risk
  50. DR Vitamins, LLC dba DR Vitamin Solutions

    FDA warned DR Vitamin Solutions that its eye drops are unapproved new drugs and misbranded.

    High risk